Related Experiment Video
Updated: Mar 24, 2026

09:44
Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
Published on: January 25, 2016
20.0K
Prognostic Factors in Sudden Sensorineural Hearing Loss
Gamze Atay1, Bahar Kayahan1, Betül Çiçek Çınar2
1Department of Otolaryngology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Balkan Medical Journal
|March 12, 2016
Summary
Early treatment for sudden sensorineural hearing loss (SSNHL) and a flat audiological pattern show positive prognostic effects. Systemic steroid therapy did not significantly influence SSNHL outcomes in this patient series.
Area of Science:
- Otolaryngology
- Audiology
- Neurology
Background:
- Sudden sensorineural hearing loss (SSNHL) presents diagnostic and therapeutic challenges.
- Identifying prognostic factors is crucial for optimizing treatment strategies for SSNHL.
Purpose of the Study:
- To investigate the correlation between SSNHL outcomes and systemic steroid therapy.
- To analyze the impact of treatment delay on SSNHL prognosis.
- To evaluate the relationship between audiological patterns and SSNHL recovery.
Main Methods:
- Retrospective chart review of 181 SSNHL patients diagnosed between May 2005 and December 2011.
- Data collected included demographics, medical history, audiological evaluations, and treatment protocols.
- Treatment timing (≤5 days vs. >5 days) and audiological patterns (upward, downward, flat, profound) were key variables.
Main Results:
- Systemic steroid administration showed no significant effect on hearing recovery in SSNHL patients.
- Early treatment (≤5 days) was associated with a statistically significant lower rate of unchanged hearing compared to delayed treatment.
- A 'flat' audiological configuration demonstrated the highest rate of slight hearing recovery.
Conclusions:
- Systemic steroid therapy does not appear to influence SSNHL outcomes.
- Early treatment initiation (within 5 days) and a 'flat' audiological pattern are potential positive prognostic indicators for SSNHL.
- Further randomized controlled trials are recommended to confirm these prognostic factors.

